1972-1984

In 1972, the first co-operation contracts were signed with Japanese pharmaceutical companies Iskra Industry and Taiho Pharmaceutical in regard to the supply of the anti-cancer agent Ftorafur. Ftorafur spreads the fame of the plant worldwide and even today this drug is still one of the products most exported by «Grindeks».

During the second half of the 1970’s, inventions from the molecular biology and microbiology laboratories were introduced into the manufacturing process, manufacturing technologies were improved and syntheses of new ingredients were mastered. The synthesis of «Grindeks»’ brand product Mildronate was commenced.

During the first half of the 1980’s, research continued in the field of peptide chemistry, work was commenced on new groups of compounds in the search for potential ingredients for medical treatment and intensive work was carried out on psychopharmacological medicines. Several new groups of medicines were added to the range of medicines manufactured at the plant, including medicines for the treatment of cardiac and vascular diseases.